The SEC classifies these issuers under “Perfumes, Cosmetics & Other Toilet Preparations” (SIC 2844). A shared code is a starting point for finding comparable businesses. Product mix, geography and customers can still differ substantially. Read the company descriptions before treating the group as direct competitors.
Align the reporting periods before comparing annual results. Companies with different year ends report different 12-month windows.
| Fiscal year end (SEC) | Companies |
|---|---|
| January 3 | KVUE |
| June 30 | EL |
| December 31 | CL |
Colgate-Palmolive is a leader in oral care and also sells personal-care, home-care, and pet-nutrition products worldwide. Its dominant global toothpaste share provides steady, recession-resistant demand.
Kenvue makes consumer-health brands including Tylenol, Band-Aid, Listerine, and Neutrogena.
Estée Lauder makes prestige skincare, makeup, and fragrance brands sold in department stores and travel retail.
Compare Colgate-Palmolive Company and The Estée Lauder Companies Inc.: business context, fiscal calendars and official filings.
Compare Colgate-Palmolive Company and Kenvue Inc.: business context, fiscal calendars and official filings.
Compare The Estée Lauder Companies Inc. and Kenvue Inc.: business context, fiscal calendars and official filings.
Industry codes and annual filing references come from the SEC submissions snapshot linked to each issuer in our company catalog (snapshot ; newer filings may exist). Only groups with at least three distinct issuers, business descriptions and annual filing links are included. Multiple share classes of one issuer count as one company. This is a coverage directory, not a complete industry census or a ranking of investments.
SEC Standard Industrial Classification code list explains the classification system. Read our research methodology or browse all industry directories.
Financials describe the business. The next question is which assumptions an investment thesis depends on. Explore the member reports below for analysis of catalysts, risks, and what would change the view. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included